Related Experiment Video
Updated: Jan 8, 2026

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
2.1K
Overactive Neuronal eEF2K/eEF2 signaling is associated with cognitive impairment and apathy-like behavior
Hannah M Jester1, Noelle Nicol1, Qian Yang1
1Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.
Molecular Psychiatry
|December 14, 2025
Summary
Overexpression of eEF2 kinase (eEF2K) in mice impairs learning, memory, and causes apathy by disrupting synaptic function. This highlights the role of eEF2K/eEF2 signaling in cognitive and neuropsychiatric disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Dysregulated protein synthesis is linked to neurodevelopmental, neurodegenerative, and neuropsychiatric diseases.
- eukaryotic elongation factor 2 (eEF2) phosphorylation by eEF2K regulates protein synthesis and is implicated in cognitive function and ketamine's antidepressant effects.
Purpose of the Study:
- To investigate the causal relationship between overactive eEF2K/eEF2 signaling and impaired synaptic and cognitive function.
- To generate and analyze a transgenic mouse model (eEF2K-cKI) overexpressing eEF2K in excitatory neurons.
Main Methods:
- Assessment of hippocampal-dependent learning and memory in eEF2K-cKI mice.
- Evaluation of neuropsychiatric behaviors including despair, anhedonia, apathy, anxiety, and sociability.
- Analysis of long-term potentiation, dendritic spine morphology, synaptic structure, and proteomic changes.
Main Results:
- eEF2K-cKI mice displayed significant learning and memory impairments.
- A robust apathy-like phenotype was observed, without other depression-like behaviors.
- Impaired long-term potentiation, altered hippocampal synaptic morphology, and changes in neuropsychiatric disorder-associated proteins were identified.
Conclusions:
- Aberrant eEF2K/eEF2 signaling plays a pathophysiological role in brain function.
- Findings provide insights into mechanisms underlying dementia and neuropsychiatric symptoms.
- This study suggests novel therapeutic avenues for neuronal diseases involving cognitive and mood impairments.
More Related Videos
Related Concept Videos
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

